Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Randomized, Double-blind, Active-controlled, Multicenter, Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

To determine the efficacy and safety of Botulax® in treatment of crow's feet line

1. Allocation: Randomized
2. Masking: Double Blind

Inclusion Criteria:

• Male or female of at least 19 to 65 years old
• Bilaterally symmetrical moderator-to-severe CFL at maximum smile on the FWS as rated by the investigator

Exclusion Criteria:

• Subject with hypersensitivity to the investigational products or their components
• Female subject who are pregnant or lactating
• Subject who are unable to communicate or follow the instructions
• Subject who are not eligible for this study based on the judgment of an investigator